sábado, 25 de octubre de 2025
XDR-TB Drug Trial Participants Continue to Celebrate its Success By Ed Holt Copyright © 2025 IPS-Inter Press Service.
Before the successful Nix-TB trial, which took place in South Africa from 2015 to 2017, patients with extensively drug-resistant TB (XDR-TB) had to follow a complicated treatment plan for the deadliest form of the disease.
https://www.ipsnews.net/2025/10/extensively-drug-resistant-tb-drug-trial-participants-celebrate-its-success-a-decade-later/
BRATISLAVA, Oct 20 2025 (IPS) - When Tsholofelo Msimango joined a small trial of a new drug regimen for tuberculosis (TB) treatment a decade ago, she had no idea whether the medicines she was about to be given would help her.
Copyright © 2025 IPS-Inter Press Service.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario